Company / Total Assets
AIM ImmunoTech Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$5.8M
FY2025
5-year range
$5.8M / $57.7M
FY2021-FY2025
Trend
-32.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 5 consecutive years, from $65M in FY2020 to $6M in FY2025.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of -38.3%.
Declined from $19M to $6M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -47.7%
- 5-Year CAGR
- -38.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- AIM ImmunoTech Inc.'s total assets has declined for 5 consecutive years.
- 5-year CAGR of -38.3%, indicating a declining trend.
- In FY2025, total assets decreased 32.8% year-over-year.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8M | -32.8% |
| FY2024 | $8.6M | -55.6% |
| FY2023 | $19.4M | -52.1% |
| FY2022 | $40.5M | -29.8% |
| FY2021 | $57.7M | -10.7% |
| FY2020 | $64.6M | +211.2% |
| FY2019 | $20.8M | +49.9% |
| FY2018 | $13.8M | -2.5% |
| FY2017 | $14.2M | -24.7% |
| FY2016 | $18.9M | -17.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026